Genlyte has a fast Ebola diagnostic test; CardioKinetix starts heart failure device trial in China;

@FierceMedDev: Mobile blood glucose monitor startup Telcare gets $33M round. Article | Follow @FierceMedDev

@VarunSaxena2: Sanofi leads $11M Series A round for needle-free delivery company. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: U.S. Department of Homeland Security investigating cybersecurity concerns for devices from $MDT, $STJ and $HSP. More | Follow @EmilyWFierce

@MichaelGFierce: Encapsulated Alzheimer's, Parkinson's-treating growth factors implanted directly in the brain. FierceDrugDelivery article | Follow @MichaelGFierce

> San Diego-based Genalyte, a diagnostic laboratory startup, has a test capable of detecting the early stages of Ebola in the blood in as little as 10 minutes. Release

> Resonetics, a company that provides laser micromachining manufacturing services for the medical device and diagnostic industries, was acquired by private equity firm Sverica International. Release

> CardioKinetix, a medical device company developing catheter-based treatments for heart failure, enrolled the first 10 patients in China a multi-center trial to evaluate the minimally invasive Parachute Ventricular Partitioning Device heart failure treatment. Release

> The U.S. Patent and Trademark Office's patent trial board ruled in favor of Becton Dickinson ($BDX) in a case about a catheter-assembly patent held by One StockDuq Holdings. Story

Biotech News

@FierceBiotech: J&J heads to Texas with its R&D farm system, scouting for biotech startups. News | Follow @FierceBiotech

@JohnCFierce: Celgene adds $1B-plus immuno-oncology deal, buyout option for Sutro, a Fierce 15 company. News | Follow @JohnCFierce

@DamianFierce: Inbox: "FDA Encourages Juice Safety This Fall"; juice safely, everyone. | Follow @DamianFierce

@EmilyMFierce: Sigh. US midterm elections offer little hope for science. More from Nature | Follow @EmilyMFierce

> Women's health biotech Forendo raises $15M from some pharma giants. Item

> Lilly bets another $375M on Zymeworks' two-pronged cancer tech. Story

> Pfizer, Novartis chip in on $17M round for an Atlas upstart focused on pain. Article

Pharma News

@FiercePharma: Top-read in FP Wednesday: $GSK dealmaking spawns management shake-up, putting Slaoui and Hussain in top slots. Article | Follow @FiercePharma

@CarlyHFierce: Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines. FierceVaccines item | More from FiercePharmaMarketing | Follow @CarlyHFierce

> Medicines Company sues lawyers for busting Angiomax patent filing deadline. Story

> Eli Lilly continues downward spiral in Q3 as generics slam Cymbalta, Evista sales. More

> Celgene's powerhouse Revlimid gets a little Q3 help from new friends Pomalyst, Otezla. Article

Vaccines News

> Could oral vaccines shake up the flu shot market? Vaxart's Ph I says maybe. More

> GSK taps Slaoui to chair flat-selling vaccines unit with an eye to the future. Story

> Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines. Item

> Ebola roundup: J&J invests $200M in R&D, Glaxo says vaccine will come too late. More

> FDA accepts app for Merck, Sanofi 6-in-1 combo vaccine. Article

Pharma Manufacturing News

> Roche, too, has big plans for improved HQ facilities. Item

> Industry faces new effort to make it pay for drug disposal. More

> Repackager mistakenly puts some ibuprofen bottles into naproxen boxes. Report

> GSK manufacturing will take hit in cost-cutting move. Story

> Argos starts work on $57M plant in North Carolina. Article

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.